L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 225.02 Million EUR | -56.57% |
| 2022 | 518.12 Million EUR | -7.78% |
| 2021 | 561.82 Million EUR | 138.25% |
| 2020 | 235.81 Million EUR | -65.52% |
| 2019 | 683.91 Million EUR | 17.05% |
| 2018 | 584.28 Million EUR | 514.45% |
| 2017 | 95.09 Million EUR | 11.57% |
| 2016 | 85.23 Million EUR | -15.3% |
| 2015 | 100.63 Million EUR | -15.92% |
| 2014 | 119.67 Million EUR | 45.46% |
| 2013 | 82.27 Million EUR | -2.86% |
| 2012 | 84.69 Million EUR | 15.68% |
| 2011 | 73.22 Million EUR | 22.29% |
| 2010 | 59.87 Million EUR | 7.88% |
| 2009 | 55.5 Million EUR | -30.87% |
| 2008 | 80.28 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 495.75 Million EUR | -4.32% |
| 2023 Q3 | 225.02 Million EUR | -54.61% |
| 2023 Q4 | 225.02 Million EUR | 0.0% |
| 2023 Q2 | 495.75 Million EUR | 0.0% |
| 2023 FY | 225.02 Million EUR | -56.57% |
| 2022 Q1 | 613.45 Million EUR | 9.19% |
| 2022 FY | 518.12 Million EUR | -7.78% |
| 2022 Q4 | 518.12 Million EUR | 0.0% |
| 2022 Q3 | 518.12 Million EUR | -15.54% |
| 2022 Q2 | 613.45 Million EUR | -0.0% |
| 2021 Q4 | 561.82 Million EUR | 0.0% |
| 2021 Q3 | 561.82 Million EUR | 78.39% |
| 2021 FY | 561.82 Million EUR | 138.25% |
| 2021 Q2 | 314.94 Million EUR | 0.0% |
| 2021 Q1 | 314.94 Million EUR | 33.56% |
| 2020 Q4 | 235.81 Million EUR | 0.0% |
| 2020 Q2 | 591.71 Million EUR | 0.0% |
| 2020 Q3 | 235.81 Million EUR | -60.15% |
| 2020 FY | 235.81 Million EUR | -65.52% |
| 2020 Q1 | 591.71 Million EUR | -13.48% |
| 2019 Q2 | 830.85 Million EUR | 0.0% |
| 2019 Q4 | 683.91 Million EUR | 0.0% |
| 2019 FY | 683.91 Million EUR | 17.05% |
| 2019 Q1 | 830.85 Million EUR | 42.2% |
| 2019 Q3 | 683.91 Million EUR | -17.68% |
| 2018 Q3 | 569.37 Million EUR | 470.23% |
| 2018 FY | 584.28 Million EUR | 514.45% |
| 2018 Q4 | 584.28 Million EUR | 2.62% |
| 2018 Q2 | 99.85 Million EUR | 17.54% |
| 2018 Q1 | 84.94 Million EUR | -10.67% |
| 2017 Q2 | 101.36 Million EUR | 15.92% |
| 2017 Q1 | 87.44 Million EUR | 2.6% |
| 2017 FY | 95.09 Million EUR | 11.57% |
| 2017 Q3 | 80.59 Million EUR | -20.49% |
| 2017 Q4 | 95.09 Million EUR | 17.99% |
| 2016 Q3 | 70.57 Million EUR | -30.81% |
| 2016 FY | 85.23 Million EUR | -15.3% |
| 2016 Q1 | 87.96 Million EUR | -12.59% |
| 2016 Q2 | 101.99 Million EUR | 15.95% |
| 2016 Q4 | 85.23 Million EUR | 20.77% |
| 2015 Q2 | 122.1 Million EUR | 11.91% |
| 2015 Q3 | 86.38 Million EUR | -29.26% |
| 2015 Q4 | 100.63 Million EUR | 16.49% |
| 2015 FY | 100.63 Million EUR | -15.92% |
| 2015 Q1 | 109.11 Million EUR | -8.83% |
| 2014 Q2 | 115.11 Million EUR | 9.91% |
| 2014 FY | 119.67 Million EUR | 45.46% |
| 2014 Q4 | 119.67 Million EUR | 11.46% |
| 2014 Q3 | 107.37 Million EUR | -6.73% |
| 2014 Q1 | 104.74 Million EUR | 27.31% |
| 2013 Q4 | 82.27 Million EUR | 11.86% |
| 2013 Q2 | 93.52 Million EUR | 9.22% |
| 2013 Q1 | 85.63 Million EUR | 1.1% |
| 2013 FY | 82.27 Million EUR | -2.86% |
| 2013 Q3 | 73.55 Million EUR | -21.36% |
| 2012 FY | 84.69 Million EUR | 15.68% |
| 2012 Q1 | 70.37 Million EUR | -3.88% |
| 2012 Q3 | 76.77 Million EUR | -10.75% |
| 2012 Q4 | 84.69 Million EUR | 10.33% |
| 2012 Q2 | 86.01 Million EUR | 22.22% |
| 2011 Q4 | 73.22 Million EUR | 0.0% |
| 2011 FY | 73.22 Million EUR | 22.29% |
| 2011 Q2 | 78.16 Million EUR | 0.0% |
| 2010 Q2 | 71.72 Million EUR | 0.0% |
| 2010 Q4 | 59.87 Million EUR | 0.0% |
| 2010 FY | 59.87 Million EUR | 7.88% |
| 2009 Q4 | 55.5 Million EUR | 0.0% |
| 2009 FY | 55.5 Million EUR | -30.87% |
| 2008 FY | 80.28 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 3.49 Million HKD | -6332.876% |
| Innovative Pharmaceutical Biotech Limited | 661.64 Million HKD | 65.991% |
| China Overseas Nuoxin International Holdings Limited | 9.2 Million HKD | -2345.36% |
| Prosperous Future Holdings Limited | 6.33 Million HKD | -3452.605% |
| Huasheng International Holding Limited | 207.84 Million HKD | -8.266% |
| Fourace Industries Group Holdings Limited | 2.39 Million HKD | -9315.146% |
| Evergreen Products Group Limited | 35.17 Million HKD | -539.776% |
| EC Healthcare | 783.75 Million HKD | 71.289% |
| Ming Fai International Holdings Limited | 2.16 Million HKD | -10298.429% |
| Blue Moon Group Holdings Limited | 101.55 Million HKD | -121.583% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | -62.536% |
| Takbo Group Holdings Limited | 7.72 Million HKD | -2811.775% |
| Hyfusin Group Holdings Limited | 8.66 Million HKD | -2495.709% |